Enfermedad de hígado graso no alcohólico y potenciales efectos de los β-glucanos en su tratamiento: Una revisión de literatura

Abstract

Non-alcoholic fatty liver disease is considered a public health problem, characterized by the accumulation of fatty acids and triglycerides in the cytoplasm of hepatocytes, resulting in an increase in the total weight of the liver, ran-ging from a non-alcoholic hepatic steatosis (absence of inflammation) to non-alcoholic steatohepatitis (presence of inflammation), fibrosis and even hepatocarcinoma. Currently, there are no treatments approved by regulatory agencies for the disease, which has led to a high prevalence of liver disease worldwide. The β-glucans are homopo-lysaccharides of glucose to which fat-reducing properties are attributed since they are considered dietary fiber. The importance and effects of β-glucans in the diet for the prevention of nonalcoholic fatty liver disease are highlighted in this literature review.